 |
||||||||||||||||||||||||||
 |
Company Strategy Atlantic Healthcare is targeting the hospital sector and medical conditions that are too specialist for, or outside the focus, of large global pharmaceutical companies Products may be granted special, orphan drug status and fast tracked through marketing approvals where use and adoption is driven by unmet or poorly satisfied needs of the most difficult patients, who are under the care of hospital specialists Atlantic Healthcare has a unique, experienced world class management team, board and advisors with a track record of identifying products that meet our criteria that the company can licence or acquire to service this sector
|
|||||||||||||||||||||||||
|
Atlantic Healthcare’s team uses innovative strategies to ensure its products are available to specialists and also create significant value and returns for shareholders Atlantic Healthcare is building a portfolio of products that address needs in clearly defined targeted group of patients for which there are poorly served needs or no approved treatment. This portfolio contains products that have unique positioning characteristics, patent protection and market exclusivity, that key medical opinion leaders have confirmed they will consider for their patients. This provides Atlantic Healthcare with the potential to be a high growth profitable company. Atlantic Healthcare’s team is focused on the unique characteristic of this sector of the pharmaceutical and healthcare industry. It is building a pipeline of similar products that it intends to acquire, building an attractive high growth specialist pharmaceutical company Key Success Factors Atlantic Healthcare has in place a number of factors in its favour for its IBD therapy that will ensure it is well placed to reach its company objectives in both the short and medium terms
|
||||||||||||||||||||||||||
Terms &
Conditions
© Atlantic Healthcare Limited, 2011. All Rights Reserved.